PPD Inc

NASDAQ:PPD   3:59:58 PM EDT
46.22
-0.06 (-0.14%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)16.23B
Current PE73.44
Forward PE 31.44
2yr Forward PE 27.35
See more stats
Estimates Current Quarter
Revenue$1.32 Billion
Adjusted EPS$0.33
See more estimates
10-Day MA$46.31
50-Day MA$46.24
200-Day MA$38.21
See more pivots

PPD Inc Stock, NASDAQ:PPD

929 North Front Street, Wilmington, North Carolina 28401
United States of America
Phone: +1.310.251.0081
Number of Employees: 26000

Description

PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC.